A 58-year-old man with Parkinson disease has been on levodopa for 3 years and now presents with involuntary choreiform movements of the limbs that occur when drug levels are at their peak. Which feature best distinguishes this adverse effect from the motor complications seen with dopamine agonist monotherapy?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.